Skip to main content
Clinical Trials/DRKS00028104
DRKS00028104
Not Yet Recruiting
N/A

Evaluation of a group-based therapy programm for the treatment of fatigue and mood and cognitive disorders in patients suffering from Post-COVID (COVID-19)

Abteilung für Psychiatrie und PsychotherapieSRH Klinikum Karlsbad-Langensteinbach0 sites48 target enrollmentFebruary 18, 2022

Overview

Phase
N/A
Intervention
Not specified
Conditions
09.9
Sponsor
Abteilung für Psychiatrie und PsychotherapieSRH Klinikum Karlsbad-Langensteinbach
Enrollment
48
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 18, 2022
End Date
TBD
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Sponsor
Abteilung für Psychiatrie und PsychotherapieSRH Klinikum Karlsbad-Langensteinbach

Eligibility Criteria

Inclusion Criteria

  • Diagnosis: ICD\-10 F06\.8 Other specified mental disordes due to brain damage and dysfunction and to physicald disease U0\.09 Post\-COVID Zustand, not otherwise specified
  • \- Persisting complaints following the infection such as Fatigue, cognitive and emotional disturbancies and impairments in the psychosocial functional level
  • \- History of an infection with SARS\-CoV\-2 confirmed by a PCR\-Test during the acute infection or a specific antibody test of antibodies against SARS\-CoV\-2 following the infection
  • \- Infection at least 3 month before inclusion in the study
  • \- Legal Age
  • \- Ability to consent

Exclusion Criteria

  • \- Legal age but not able to consent
  • \- lacking knowledge of the german language
  • \- intellectual impairment

Outcomes

Primary Outcomes

Not specified

Similar Trials